IL128345A - Enhanced contrast agent for ultrasound imaging of the liver - Google Patents

Enhanced contrast agent for ultrasound imaging of the liver

Info

Publication number
IL128345A
IL128345A IL12834597A IL12834597A IL128345A IL 128345 A IL128345 A IL 128345A IL 12834597 A IL12834597 A IL 12834597A IL 12834597 A IL12834597 A IL 12834597A IL 128345 A IL128345 A IL 128345A
Authority
IL
Israel
Prior art keywords
liver
contrast agent
ultrasound imaging
enhanced contrast
phospholipid
Prior art date
Application number
IL12834597A
Other languages
English (en)
Original Assignee
Amersham Health As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9616301.9A external-priority patent/GB9616301D0/en
Priority claimed from GBGB9705918.2A external-priority patent/GB9705918D0/en
Application filed by Amersham Health As filed Critical Amersham Health As
Publication of IL128345A publication Critical patent/IL128345A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Acoustics & Sound (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
IL12834597A 1996-08-02 1997-08-04 Enhanced contrast agent for ultrasound imaging of the liver IL128345A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9616301.9A GB9616301D0 (en) 1996-08-02 1996-08-02 Improvements in or relating to contrast agents
GBGB9705918.2A GB9705918D0 (en) 1997-03-21 1997-03-21 Improvements in or relating to contrast agents
PCT/GB1997/002119 WO1998005364A2 (en) 1996-08-02 1997-08-04 Improvements in or relating to contrast agents

Publications (1)

Publication Number Publication Date
IL128345A true IL128345A (en) 2003-06-24

Family

ID=26309806

Family Applications (2)

Application Number Title Priority Date Filing Date
IL12834597A IL128345A (en) 1996-08-02 1997-08-04 Enhanced contrast agent for ultrasound imaging of the liver
IL12934597A IL128345A0 (en) 1996-08-02 1997-08-04 Improvements in or relating to contrast agents

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL12934597A IL128345A0 (en) 1996-08-02 1997-08-04 Improvements in or relating to contrast agents

Country Status (16)

Country Link
US (1) US7892522B2 (zh)
EP (1) EP0918546B1 (zh)
JP (2) JP3634869B2 (zh)
KR (1) KR100593873B1 (zh)
CN (1) CN1104911C (zh)
AT (1) ATE411055T1 (zh)
AU (1) AU3780497A (zh)
CA (1) CA2262908A1 (zh)
CZ (1) CZ28999A3 (zh)
DE (1) DE69739047D1 (zh)
ES (1) ES2316157T3 (zh)
IL (2) IL128345A (zh)
MX (1) MXPA99001053A (zh)
NO (1) NO990276L (zh)
NZ (1) NZ334365A (zh)
WO (1) WO1998005364A2 (zh)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9708246D0 (en) * 1997-04-24 1997-06-18 Nycomed Imaging As Improvements in or relating to ultrasound imaging
GB9717589D0 (en) * 1997-08-19 1997-10-22 Nycomed Imaging As Improvements in or relating to contrast agents
GB9809084D0 (en) * 1998-04-28 1998-06-24 Nycomed Imaging As Improvements in or relating to diagnostic/therapeutic agents
US6548048B1 (en) 1998-04-28 2003-04-15 Amersham Health As Lipopeptide stabilized microbubbles as diagnostic/therapeutic agents
US6984373B2 (en) 2000-12-23 2006-01-10 Dyax Corp. Fibrin binding moieties useful as imaging agents
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
US20050100963A1 (en) 2002-03-01 2005-05-12 Dyax Corporation KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
EP1572724A4 (en) 2002-03-01 2007-03-14 Dyax Corp KDR AND VEGF / KDR BINDING SPEPTIDES AND THEIR USE IN DIAGNOSIS AND THERAPY
NO20024755D0 (no) * 2002-10-03 2002-10-03 Amersham Health As Metode
US9364569B2 (en) * 2003-02-04 2016-06-14 Bracco Suisse S.A. Ultrasound contrast agents and process for the preparation thereof
AU2004217894B2 (en) 2003-03-03 2010-07-15 Bracco International B.V. Peptides that specifically bind HGF receptor (cMet) and uses thereof
WO2005063305A1 (en) 2003-12-22 2005-07-14 Bracco Research Sa Gas-filled microvesicle assembly for contrast imaging
US8357351B2 (en) 2004-04-21 2013-01-22 Ananth Annapragada Nano-scale contrast agents and methods of use
US7713517B2 (en) * 2004-04-21 2010-05-11 Marval Biosciences, Inc. Compositions and methods for enhancing contrast in imaging
EP1784228B1 (en) 2004-08-18 2016-10-05 Bracco Suisse SA Gas-filled microvesicles composition for contrast imaging
WO2006076826A1 (fr) * 2005-01-18 2006-07-27 Institute Of Pharmacology Toxicology, Academy Of Military Medical Sciences Composition de contraste pour ultrasons utilisant un phospholipide filmogene et procede de preparation de celle-ci
JP2006335745A (ja) * 2005-06-06 2006-12-14 Fujifilm Holdings Corp リポソームを含むｍｒｉ造影剤
CN100453050C (zh) * 2005-09-21 2009-01-21 北京市肿瘤防治研究所 提高超声造影图像分辨力的方法和超声造影成像仪
EP1966388B1 (en) 2005-12-09 2013-08-07 Bracco Suisse SA Targeting vector-phospholipid conjugates
US20070140973A1 (en) * 2005-12-15 2007-06-21 Bristol-Myers Squibb Pharma Company Contrast agents for myocardium perfusion imaging
EP2217146A4 (en) 2007-12-05 2015-10-14 Marval Biosciences Inc NANOMETRIC SCALE CONTRAST AGENTS AND METHODS OF USE
US20090311191A1 (en) * 2008-06-13 2009-12-17 Ananth Annapragada Imaging of atherosclerotic plaques using liposomal imaging agents
GB0811856D0 (en) * 2008-06-27 2008-07-30 Ucl Business Plc Magnetic microbubbles, methods of preparing them and their uses
WO2012136813A2 (en) 2011-04-07 2012-10-11 Universitetet I Oslo Agents for medical radar diagnosis
EP2844362B1 (en) 2012-04-30 2020-02-26 Ge Healthcare As Method for filling a container with a foamable composition
WO2014142927A1 (en) * 2013-03-14 2014-09-18 Empire Technology Development Llc Identification of surgical smoke
US10155063B2 (en) * 2015-11-12 2018-12-18 University Of Virginia Patent Foundation Methods for vas-occlusive contraception and reversal thereof
CN107233583B (zh) * 2016-03-29 2020-04-24 北京飞锐达医疗科技有限公司 一种具有超长持续时间的超声造影剂及其制备方法
WO2018129369A1 (en) 2017-01-05 2018-07-12 Contraline, Inc. Methods for implanting and reversing stimuli-responsive implants
JP2022506078A (ja) 2018-11-13 2022-01-17 コントラライン，インコーポレイテッド 生体材料を送達するためのシステムおよび方法
GB201821049D0 (en) * 2018-12-21 2019-02-06 Ge Healthcare As Ultrasound contrast agent and methods for use therof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2129685B (en) * 1982-11-11 1985-11-13 Nat Biolog Standards Board Anti-haemophilic compositions
US5773024A (en) * 1989-12-22 1998-06-30 Imarx Pharmaceutical Corp. Container with multi-phase composition for use in diagnostic and therapeutic applications
US5445813A (en) * 1992-11-02 1995-08-29 Bracco International B.V. Stable microbubble suspensions as enhancement agents for ultrasound echography
DE4100470A1 (de) * 1991-01-09 1992-07-16 Byk Gulden Lomberg Chem Fab Echokontrastmittel
CN1148812A (zh) * 1994-03-28 1997-04-30 尼科梅德成像有限公司 “脂质体”
US5540909A (en) * 1994-09-28 1996-07-30 Alliance Pharmaceutical Corp. Harmonic ultrasound imaging with microbubbles
HU229090B1 (en) * 1996-02-19 2013-07-29 Ge Healthcare As Improvements in or relating to contrast agents
CA2246778A1 (en) * 1996-02-19 1997-08-21 Per Helge Gulliksen Thermally stabilized contrast agent
US5837221A (en) * 1996-07-29 1998-11-17 Acusphere, Inc. Polymer-lipid microencapsulated gases for use as imaging agents
US6054118A (en) * 1997-01-22 2000-04-25 Nycomed Imaging As Contrast agents comprising two types of gas-containing microparticles

Also Published As

Publication number Publication date
JP2000517296A (ja) 2000-12-26
NO990276D0 (no) 1999-01-22
EP0918546A2 (en) 1999-06-02
CN1227502A (zh) 1999-09-01
MXPA99001053A (es) 2002-03-11
ATE411055T1 (de) 2008-10-15
WO1998005364A2 (en) 1998-02-12
EP0918546B1 (en) 2008-10-15
NO990276L (no) 1999-01-22
CN1104911C (zh) 2003-04-09
IL128345A0 (en) 2000-01-31
WO1998005364A3 (en) 1998-06-18
NZ334365A (en) 1999-10-28
KR100593873B1 (ko) 2006-07-03
JP2004002453A (ja) 2004-01-08
US20020106328A1 (en) 2002-08-08
CZ28999A3 (cs) 1999-07-14
US7892522B2 (en) 2011-02-22
JP3634869B2 (ja) 2005-03-30
DE69739047D1 (de) 2008-11-27
CA2262908A1 (en) 1998-02-12
AU3780497A (en) 1998-02-25
KR20000029780A (ko) 2000-05-25
ES2316157T3 (es) 2009-04-01

Similar Documents

Publication Publication Date Title
IL128345A (en) Enhanced contrast agent for ultrasound imaging of the liver
HK1028548A1 (en) Formulations for hydrophobic pharmaceutical agents
PH12012000094A1 (en) Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
AU2427601A (en) Radiation sensitive liposomes
PL339654A1 (en) Creation of peptide/lipide complexes by co-lyophilising process
ATE329897T1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiven substanzen
CA2259179A1 (en) Emulsion formulations for hydrophilic active agents
FI971776A (fi) Yhdisteet ja koostumukset aktiivisten aineiden antamiseksi
AU3559895A (en) Polyethylene glycol modified ceramide lipids and liposome uses thereof
GR3034204T3 (en) Lipopolyamines as transfection agents and pharmaceutical uses thereof
DE69623087T2 (de) Brausemittel und dessen Herstellung
WO1995022992A8 (en) Method and compositions for increasing the serum half-life of pharmacologically active agents
AU6185398A (en) Charged lipids and uses for the same
NO994621L (no) Ernaeringsformuleringer inneholdende oligosakkarider
AU4786697A (en) Improvements in or relating to diagnostic/therapeutic agents
AU4711296A (en) Method for loading lipid vesicles
CA2439500A1 (en) Drug delivery system for hydrophobic drugs
HUP9903823A3 (en) Use of sibutramine analogues for the preparation of pharmaceutical compositions suitable for lowering lipid levels
HUP0000501A3 (en) Oil-in-water emulsions for reconstituting lamellarity of the lipid structure of damaged skin
BE1014502A5 (fr) Compositions pharmaceutiques.
DE69120287D1 (en) Aminosulfonylharnstoff-acat-inhibitoren
ZA963743B (en) Transdermal therapeutic system (TTS) for the administration of testosterone
CO4910129A1 (es) Composiciones farmaceuticas que contienen derivados de n-sulfonil indolina
NO973666D0 (no) Kontrastmiddelholdige liposomer for avbildning av det intravaskulære rom
DE69520231D1 (de) Liposomzubereitungen enthaltend hybrid-interferon

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees
HC Change of name of proprietor(s)

Owner name: GE HEALTHCARE AS

Free format text: FORMER NAME:AMERSHAM HEALTH AS